Helicobacter pylori: From the benign to the malignant

American Journal of Gastroenterology

Volumn 94, Issue 11 SUPPL., 1999, Pages

  Williams, Matthew P ^a   Pounder, Roy E ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER PREVENTION; CANCER RISK; ESOPHAGUS CANCER; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; PEPTIC ULCER; PRIORITY JOURNAL; STOMACH CANCER;

DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PEPTIC ULCER; RISK FACTORS; STOMACH NEOPLASMS;

EID: 0032719646     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(99)00657-7     Document Type: Article

References (41)

1. Parsonnet J. Helicobacter pylori The size of the problem . Gut. 43:(suppl 1):1998;S6-S9.
2. Kuipers E.J. Helicobacter pylori and the risk and management of associated diseases Gastritis, ulcer disease, atrophic gastritis and gastric cancer . Aliment Pharmacol Ther. 11:(suppl 1):1997;71-88.
3. Kuipers E.J. Relationship between Helicobacter pylori, atrophic gastritis and gastric cancer. Aliment Pharmacol Ther. 12:(suppl 1):1998;25-36.
4. Vaira D., Miglioli M., Mule P., et al. Prevalence of peptic ulcer in Helicobacter pylori positive blood donors. Gut. 35:1994;309-312.
5. Maher W., Jyotheeswaran S., Potter G., et al. An epidemiological study of peptic ulcer disease patients in greater Rochester, New York. Gastroenterology. 112:1997;A206. (abstract).
6. Gislason G.T., Emu B., Okolo P., et al. Where have all the Helicobacter gone Etiological factors in patients with duodenal ulcers (DU) presenting to a university hospital . Gastrointest Endosc. 45:1997;AB90. (abstract).
7. Correa P., Haenszel W., Cuello C., et al. A model for gastric cancer epidemiology. Lancet. 2:1975;58-59.
8. Correa P. Human gastric carcinogenesis A multistep and multifactorial process. First American Cancer Society award lecture on cancer epidemiology and prevention . Cancer Res. 52:1992;6735-6740.
9. Kuipers E.J., Uyterlinde A.M., Peña A.S., et al. Long term sequelae of Helicobacter pylori gastritis. Lancet. 345:1995;1525-1528.
10. Sonnenberg A. Temporal trends and geographical variations of peptic ulcer disease. Aliment Pharmacol Ther. 9:(suppl 2):1995;3-12.
11. Fuchs C.S., Mayer R.J. Gastric carcinoma. N Engl J Med. 333:1995;32-41.
12. IARC monographs on the evaluation of carcinogenic risks to humans: Schistosomes, liver flukes and Helicobacter pylori. Vol 61:1994;IARC, Lyon, France.
13. Forman D., Webb P., Parsonnet J. H pylori and gastric cancer. Lancet. 343:1994;243-244.
14. Huang J.-Q., Sridhar S., Chen Y., et al. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology. 114:1998;1169-1179.
15. Watanabe T., Tada M., Hirofumi N., et al. Helicobacter pylori infection induces gastric cancer in Monogolian gerbils. Gastroenterology. 115:1998;642-648.
16. Hansson L.E., Nyren O., Hsing A.W., et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med. 335:1996;242-249.
17. Uemura N., Mukai T., Okamoto S., et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev. 6:1997;639-642.
18. Parsonnet J., Harris R.A., Hack H.M., et al. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer A mandate for clinical trials . Lancet. 348:1996;150-154.
19. La Vecchia C., Negri E., Franceschi S., et al. Family history and the risk of stomach and colorectal cancer. Cancer. 70:1992;50-55.
20. Simán J.H., Forsgren G., Berglund G., et al. Tobacco smoking and Helicobacter pylori infection are risk factors of gastric adenocarcinoma. Gut. 43:(suppl 2):1998;A63. (abstract).
21. Malfertheiner P., Gerards C., Leodolter A., et al. Pitfalls in Helicobacter pylori diagnosis. Hunt R.H., Tytgat G.N.J. Helicobacter pylori. Basic mechanisms to clinical cure. 1998;274-292 Kluwer Academic Publishers, Dordrecht.
22. Hopkins R.J., Girardi L.S., Turney E.A. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence A review . Gastroenterology. 110:1996;1244-1252.
23. Blot W.J., Devesa S.S., Kneller R.W., et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 265:1991;1287-1289.
24. El-Serag H.B., Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut. 43:1998;327-333.
25. Blaser M.J. Science, medicine, and the future - Helicobacter pylori and gastric diseases. BMJ. 316:1998;1507-1510.
26. Newton M., Bryan R., Burnham W.R., et al. Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus. Gut. 40:1997;9-13.
27. Labenz J., Blum A.L., Bayerdörffer E., et al. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux oesophagitis. Gastroenterology. 112:1997;1442-1447.
28. Ödman B., Lindberg G., Befrits R., et al. Symptoms of gastro-oesophageal reflux in duodenal ulcer patients after treatment for Helicobacter pylori during a two-year follow-up. Gastroenterology. 114:1998;A1005. (abstract).
29. Mantzaris G.J., Archavlis E.M., Kourtessas D., et al. Oesophagitis does not develop frequently after eradication of Helicobacter pylori infection. Gut. 43:(suppl 2):1998;A96. (abstract).
30. McColl K.E. Helicobacter pylori and acid secretion Where are we now? Eur J Gastroenterol Hepatol. 9:1997;333-335.
31. El-Omar E.M., Oien K., El-Nujumi A., et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology. 113:1997;15-24.
32. Parsonnet J., Friedman G.D., Orentreich N., et al. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut. 40:1997;297-301.
33. Vicari J.J., Peek R.M., Falk G.W., et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology. 115:1998;50-57.
34. + strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res. 58:1998;588-590.
35. Pipkin G.A., Williamson R., Wood J.R. One-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori. Aliment Pharmacol Ther. 12:1998;823-837.
36. Fujiyama K., Fujioka T., Kodama R., et al. Effect of E3810, a novel proton pump inhibitor, against Helicobacter pylori. Am J Gastroenterol. 89:1994;1371. (abstract).
37. Catalano F., Branciforte G., Bentivegna C., et al. Duodenal ulcer and functional dyspepsia Different susceptibility of Helicobacter pylori to eradication therapy . Helicobacter. 2:1997;106. (letter).
38. Stack W.A., Knifton A., Thirlwell D., et al. Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration. Am J Gastroenterol. 93:1998;1909-1913.
39. Broutet N., Marais A., Liu D., et al. Cag negative status A risk factor for failure of Helicobacter pylori triple therapies in non-ulcer dyspepsia . Gut. 43:(suppl 2):1998;A79. (abstract).
40. Blaser M.J. Not all Helicobacter pylori strains are created equal Should all be eliminated? Lancet. 349:1997;1020-1022.
41. Mitchell H.M., Hazell S.L., Li Y.Y., et al. Serological response to specific Helicobacter pylori antigens Antibody against CagA antigen is not predictive of gastric cancer in a developing country . Am J Gastroenterol. 91:1996;1785-1788.